Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Lucid Diagnostics (LUCD) Equity Ratio (2021 - 2025)

Lucid Diagnostics' Equity Ratio history spans 5 years, with the latest figure at 0.27 for Q4 2025.

  • For Q4 2025, Equity Ratio rose 54.05% year-over-year to 0.27; the TTM value through Dec 2025 reached 0.27, up 54.05%, while the annual FY2025 figure was 0.27, 54.05% up from the prior year.
  • Equity Ratio reached 0.27 in Q4 2025 per LUCD's latest filing, down from 0.49 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.93 in Q4 2021 to a low of 7.32 in Q3 2021.
  • Average Equity Ratio over 5 years is 0.03, with a median of 0.36 recorded in 2024.
  • Peak YoY movement for Equity Ratio: surged 307.11% in 2024, then crashed 144.18% in 2025.
  • A 5-year view of Equity Ratio shows it stood at 0.93 in 2021, then decreased by 23.59% to 0.71 in 2022, then crashed by 111.95% to 0.08 in 2023, then surged by 307.11% to 0.18 in 2024, then surged by 54.05% to 0.27 in 2025.
  • Per Business Quant, the three most recent readings for LUCD's Equity Ratio are 0.27 (Q4 2025), 0.49 (Q3 2025), and 0.2 (Q2 2025).